Tokyo, Japan

Tsukasa Ishihara



 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Ibaraki, JP (1998)
  • Tsukuba, JP (2001 - 2012)
  • Tokyo, JP (2010 - 2020)

Company Filing History:


Years Active: 1998-2020

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: **The Innovative Journey of Tsukasa Ishihara**

Introduction

Tsukasa Ishihara, an esteemed inventor based in Tokyo, Japan, has made significant contributions to the pharmaceutical field with a remarkable portfolio of 15 patents. His work focuses on innovative compounds that serve therapeutic purposes, showcasing his dedication to enhancing medical treatments, particularly for gastrointestinal disorders.

Latest Patents

One of his most notable patents involves a tetrahydroisoquinolin-1-one derivative, which has promising applications in treating irritable bowel syndrome (IBS). This pharmaceutical compound, characterized by an amide group at the 4-position, demonstrates excellent antagonistic action on the bombesin 2 (BB2) receptor. Clinical findings reveal that this derivative is highly effective in addressing bowel movement disorders, positioning it as a crucial therapeutic agent for diseases associated with the BB2 receptor, especially IBS.

Career Highlights

Tsukasa Ishihara's career is marked by his roles in prestigious pharmaceutical companies such as Astellas Pharma GmbH and Seldar Pharma Inc. His experiences in these organizations have furnished him with the knowledge and expertise to develop groundbreaking therapies that address unmet medical needs.

Collaborations

Throughout his career, Ishihara has collaborated with notable colleagues, including Norio Seki and Hiroyuki Hisamichi. These partnerships have enhanced his research initiatives and facilitated the development of innovative pharmaceutical solutions.

Conclusion

In summary, Tsukasa Ishihara stands out as a pioneering inventor in the realm of pharmaceuticals. His dedication to creating effective therapeutic agents, combined with his impressive patent portfolio, underscores his impactful contributions to medical science in Japan and beyond. As research continues, his innovations hold the potential to transform treatment methodologies for conditions like irritable bowel syndrome.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…